Valuation: Virbac

Market Cap 2.54B 2.9B 2.4B 2.19B 4.1B 278B 4.13B 28.75B 11.14B 142B 10.88B 10.65B 456B P/E 2026 *
14.7x
P/E 2027 * 13.2x
Enterprise Value 2.67B 3.04B 2.52B 2.29B 4.3B 291B 4.33B 30.13B 11.67B 149B 11.41B 11.16B 478B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.57x
Free-Float
49.03%
Yield 2026 *
0.57%
Yield 2027 * 0.67%
1 day+0.50%
1 week-2.25%
Current month-5.89%
1 month-8.58%
3 months-11.26%
6 months-14.63%
Current year-15.10%
1 week 301
Extreme 301
312.5
1 month 297
Extreme 297
327
Current year 297
Extreme 297
389.5
1 year 297
Extreme 297
389.5
3 years 242
Extreme 242
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
22/4/24 Sell

Chief Executive Officer

810 0.0096%
22/4/24 Sell

Chief Executive Officer

140 0.0017%
22/4/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-2.25%-3.19%+22.87% 2.9B
+1.11%-0.49%-50.49%-59.83% 29.36B
-0.18%-0.49%+13.77%+96.56% 11.15B
-3.46%-2.53%-14.13%-2.88% 3.71B
+0.71%+0.71%+23.27%+47.11% 1.9B
-2.98%-2.81%+22.06%+22.06% 1.85B
+1.53%-0.32%-11.23%+164.80% 1.4B
-2.80%-0.60%-20.40%-8.96% 1.13B
-0.60%+0.30%-5.95%-40.29% 1.01B
0.00%+2.58%-2.33%-1.95% 1B
Average -0.62%-0.59%-4.86%+23.95% 5.54B
Weighted average by Cap. +0.24%-0.68%-24.41%-5.71%

Financials

2026 *2027 *
Net sales 1.55B 1.76B 1.46B 1.33B 2.49B 169B 2.51B 17.49B 6.77B 86.34B 6.62B 6.48B 277B 1.64B 1.87B 1.55B 1.42B 2.65B 180B 2.67B 18.58B 7.2B 91.75B 7.04B 6.88B 295B
Net income 174M 198M 164M 150M 280M 18.99B 282M 1.97B 761M 9.7B 744M 728M 31.19B 194M 221M 183M 167M 312M 21.16B 314M 2.19B 848M 10.81B 829M 811M 34.74B
Net Debt 122M 139M 116M 105M 197M 13.37B 199M 1.38B 536M 6.83B 524M 512M 21.95B 44.72M 50.96M 42.24M 38.49M 72.05M 4.88B 72.56M 505M 196M 2.5B 191M 187M 8.02B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
25/09/26 €303.50 +0.50% 4,384
24/09/26 €302.00 -0.82% 4,422
23/09/26 €304.50 -0.98% 6,681
22/09/26 €307.50 0.00% 6,826
21/09/26 €307.50 -0.97% 4,906
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
303.50EUR
Average target price
412.75EUR
Spread / Average Target
+36.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock